SEC 13F Intelligence

Rock Springs Capital Management LP / SMMT

Rock Springs Capital Management LP’s Summit Therapeutics Inc Position

Does Rock Springs Capital Management LP own Summit Therapeutics Inc (SMMT)? Yes — 710.0K shares worth $13M (+0.79% of its 13F portfolio) as of Q1 2026.

Position Value
$13M
Q1 2026
Shares
710.0K
% of Portfolio
+0.79%
Quarters Held
7
currently held

Position History SMMT

Reported value by quarter
Q3 ’24: $23MQ3 ’24Q4 ’24: $19MQ4 ’24Q1 ’25: $19MQ1 ’25Q2 ’25: $15MQ2 ’25Q3 ’25: $15MQ3 ’25Q4 ’25: $12MQ4 ’25Q1 ’26: $13MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026710.0K$13M+0.79%
Q4 2025710.0K$12M+0.64%
Q3 2025710.0K$15M+0.86%
Q2 2025710.0K$15M+0.94%
Q1 2025995.0K$19M+1.10%
Q4 20241.05M$19M+0.72%
Q3 20241.04M$23M+0.74%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rock Springs Capital Management LP’s full portfolio or all institutional holders of SMMT.